Cargando…

CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613498/
https://www.ncbi.nlm.nih.gov/pubmed/36709176
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.014
_version_ 1784820006047973376
collection PubMed
description
format Online
Article
Text
id pubmed-9613498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-96134982022-11-16 CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略 Zhonghua Xue Ye Xue Za Zhi 综述 Editorial office of Chinese Journal of Hematology 2022-09 /pmc/articles/PMC9613498/ /pubmed/36709176 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.014 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 综述
CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title_full CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title_fullStr CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title_full_unstemmed CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title_short CD19嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的复发机制及应对策略
title_sort cd19嵌合抗原受体t细胞治疗弥漫大b细胞淋巴瘤的复发机制及应对策略
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613498/
https://www.ncbi.nlm.nih.gov/pubmed/36709176
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.014
work_keys_str_mv AT cd19qiànhékàngyuánshòutǐtxìbāozhìliáomímàndàbxìbāolínbāliúdefùfājīzhìjíyīngduìcèlüè
AT cd19qiànhékàngyuánshòutǐtxìbāozhìliáomímàndàbxìbāolínbāliúdefùfājīzhìjíyīngduìcèlüè